Header Logo

Connection

SRIDEVI DEVARAJ to Metabolic Syndrome

Back to Details
This is a "connection" page, showing publications SRIDEVI DEVARAJ has written about Metabolic Syndrome.
SRIDEVI DEVARAJ
Connection Strength
8.994
Metabolic Syndrome
  1. Potential implications of redefining the hypertriglyceridemia of metabolic syndrome. Horm Mol Biol Clin Investig. 2019 06 20; 40(1).
    View in: PubMed
    Score: 0.501
  2. Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes. Curr Diab Rep. 2018 10 18; 18(12):129.
    View in: PubMed
    Score: 0.478
  3. Subcutaneous adipose tissue biology in metabolic syndrome. Horm Mol Biol Clin Investig. 2018 Jan 20; 33(1).
    View in: PubMed
    Score: 0.454
  4. Factors that promote macrophage homing to adipose tissue in metabolic syndrome. J Diabetes Complications. 2016 Nov - Dec; 30(8):1434-1436.
    View in: PubMed
    Score: 0.410
  5. Monocyte cell adhesion molecule receptors in nascent metabolic syndrome. Clin Biochem. 2016 Apr; 49(6):505-507.
    View in: PubMed
    Score: 0.393
  6. Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome. Metab Syndr Relat Disord. 2015 Dec; 13(10):477-80.
    View in: PubMed
    Score: 0.389
  7. Monocytes from metabolic syndrome subjects exhibit a proinflammatory M1 phenotype. Metab Syndr Relat Disord. 2014 Sep; 12(7):362-6.
    View in: PubMed
    Score: 0.352
  8. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab. 2014 Jan; 99(1):39-48.
    View in: PubMed
    Score: 0.342
  9. Increased expression of Fc-? receptors on monocytes in patients with nascent metabolic syndrome. J Clin Endocrinol Metab. 2013 Sep; 98(9):E1510-5.
    View in: PubMed
    Score: 0.333
  10. Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Metab Syndr Relat Disord. 2013 Feb; 11(1):35-40.
    View in: PubMed
    Score: 0.315
  11. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012 Apr; 35(4):900-4.
    View in: PubMed
    Score: 0.301
  12. Dysfunctional endothelial progenitor cells in metabolic syndrome. Exp Diabetes Res. 2012; 2012:585018.
    View in: PubMed
    Score: 0.293
  13. Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? Curr Atheroscler Rep. 2011 Feb; 13(1):31-42.
    View in: PubMed
    Score: 0.280
  14. Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome. Am J Cardiol. 2010 Dec 01; 106(11):1606-8.
    View in: PubMed
    Score: 0.273
  15. Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep. 2010 Mar; 12(2):110-8.
    View in: PubMed
    Score: 0.263
  16. Statin therapy for the metabolic syndrome: the evidence base. Metab Syndr Relat Disord. 2009 Oct; 7(5):393-6.
    View in: PubMed
    Score: 0.255
  17. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009 Jun; 20(3):182-9.
    View in: PubMed
    Score: 0.250
  18. High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism. 2008 Jun; 57(6):867-70.
    View in: PubMed
    Score: 0.233
  19. CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers. Am J Clin Pathol. 2008 May; 129(5):815-22.
    View in: PubMed
    Score: 0.231
  20. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med. 2008 Mar 15; 44(6):1203-8.
    View in: PubMed
    Score: 0.226
  21. Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome. Am J Cardiol. 2007 Nov 01; 100(9):1397-9.
    View in: PubMed
    Score: 0.220
  22. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab. 2006 Nov; 91(11):4489-96.
    View in: PubMed
    Score: 0.207
  23. The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024 Dec 23; 23(1):416.
    View in: PubMed
    Score: 0.183
  24. Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status. Endocrinol Metab Clin North Am. 2004 Jun; 33(2):431-53, table of contents.
    View in: PubMed
    Score: 0.176
  25. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003 Jan 28; 107(3):398-404.
    View in: PubMed
    Score: 0.161
  26. Metabolites that activate the inflammasome in nascent metabolic syndrome. J Diabetes Complications. 2021 03; 35(3):107836.
    View in: PubMed
    Score: 0.139
  27. Intermittent fasting from dawn to sunset for four consecutive weeks induces anticancer serum proteome response and improves metabolic syndrome. Sci Rep. 2020 10 27; 10(1):18341.
    View in: PubMed
    Score: 0.138
  28. Increased inflammasome activity in subcutaneous adipose tissue of patients with metabolic syndrome. Diabetes Metab Res Rev. 2021 03; 37(3):e3383.
    View in: PubMed
    Score: 0.135
  29. Increased eosinophils in adipose tissue of metabolic syndrome. J Diabetes Complications. 2019 08; 33(8):535-538.
    View in: PubMed
    Score: 0.125
  30. Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis. Am J Physiol Endocrinol Metab. 2019 03 01; 316(3):E504-E509.
    View in: PubMed
    Score: 0.121
  31. Exploratory lipidomics in patients with nascent Metabolic Syndrome. J Diabetes Complications. 2018 08; 32(8):791-794.
    View in: PubMed
    Score: 0.116
  32. The effect of increasing tertiles of waist circumference on cardio-metabolic risk, adipokines and biomarkers of inflammation and oxidative stress in nascent metabolic syndrome. J Diabetes Complications. 2018 04; 32(4):379-383.
    View in: PubMed
    Score: 0.114
  33. Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome. Atherosclerosis. 2015 Jul; 241(1):130-7.
    View in: PubMed
    Score: 0.094
  34. Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines. Metab Syndr Relat Disord. 2014 Dec; 12(10):503-7.
    View in: PubMed
    Score: 0.090
  35. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013 Mar; 98(3):E514-7.
    View in: PubMed
    Score: 0.080
  36. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. J Clin Endocrinol Metab. 2012 Oct; 97(10):E1844-50.
    View in: PubMed
    Score: 0.078
  37. Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011 Nov; 96(11):E1782-8.
    View in: PubMed
    Score: 0.073
  38. Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndrome. Metab Syndr Relat Disord. 2008 Jun; 6(2):149-52.
    View in: PubMed
    Score: 0.058
  39. Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome. Am J Cardiol. 2008 Aug 01; 102(3):321-5.
    View in: PubMed
    Score: 0.058
  40. Therapy and clinical trials. Curr Opin Lipidol. 2007 Aug; 18(4):479-81.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.